The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

biotech facts fallacies

Podcast: Recent study poses new glyphosate-cancer link. Plant geneticist Kevin Folta breaks down the data

, | September 23, 2019
CO-HOST OVERVIEW
Cameron English: GLP Senior Agricultural Genetics Editor Cameron English co-hosts the Biotech Facts and Fallacies podcast with Steve Savage.    More details
Steve Savage: Steve Savage, plant pathologist and agriculture industry consultant, co-hosts the Biotech Facts and Fallacies podcast with Cameron English.    More details

Despite the endless stream of dramatic headlines and warnings from environmental activist groups, an overwhelming number of studies indicate that glyphosate, the active ingredient in Bayer’s herbicide Roundup, probably doesn’t cause cancer. This body of consensus science includes hundreds of independent papers and dozens of safety assessments conducted by 15 regulatory agencies worldwide. So comprehensive is this research, according to cancer epidemiologist Geoffrey Kabat, scientists are running out of ways to confirm the relative safety of glyphosate.

But several experiments conducted in recent years have challenged the mainstream view on Roundup safety, indicating that the controversial weed killer may increase your risk for certain cancers. A study published in July 2019 offers a typical example. The researchers exposed mutant lab mice to glyphosate for up to 72 weeks and reported at the end of their study:

These data support glyphosate as an environmental risk factor for [multiple myeloma] MM and potentially [non-Hodgkin’s Lymphoma] NHL and implicate a mechanism underlying the B cell-specificity of glyphosate-induced carcinogenesis observed epidemiologically.

The research was promoted by anti-GMO activists, including Gary Ruskin, co-founder of U.S. Right to Know. The organic industry-funded outfit has played a pivotal role in the ongoing glyphosate-cancer lawsuits against Bayer, supplying evidence to the plaintiffs and providing favorable PR for every case that goes to trial.

screenshot glyphosate induces benign monoclonal gammopathy and promotes multiple myeloma progression in mice t

There was nothing inherently wrong with the research, but Ruskin failed to mention dozens of serious limitations in the study. For example, mice were given massive doses of glyphosate—enough weed killer to treat 31 square meters of farmland—for a year and a half. This is, needless to say, far more herbicide than any animal or human is actually exposed to in the real world. The study authors acknowledged this in their paper, noting that “an individual would unlikely consume such an excessive dose of glyphosate ….” They nonetheless concluded that “the [acceptable daily intake] for glyphosate should be reassessed ….”

Related article:  Food scientist Marion Nestle: Meat industry hires 'zombie' lobbyist group to attack Beyond, Impossible Burgers

But feeding mice enormous amounts of weed killer was just one of several important issues with this research that need to be addressed. University of Florida plant geneticist Kevin Folta joins GLP editor Cameron English to take a detailed look at the study. What did the researchers really find, and how should we interpret their results? Folta’s analysis underscores the importance of approaching news reports and scientific research skeptically, carefully examining the evidence before jumping to conclusions.

Kevin M. Folta is a professor in the Horticultural Sciences Department at the University of Florida. Follow professor Folta on Twitter @kevinfolta and email your questions to [email protected]

Cameron J. English is the GLP’s senior agricultural genetics and special projects editor. He co-hosts the Biotech Facts and Fallacies podcast. Follow him on Twitter @camjenglish

GLP Podcast Hosts

Listen to more episodes

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend